In October 2022, NCI published two new funding opportunity announcements (FOAs) to address knowledge gaps and build an evidence base regarding #cannabis and cannabinoid use during #CancerTreatment. Learn about the FOAs.
People living with a chronic condition like heart disease, asthma, cancer, or diabetes should get a flu shot if they haven’t already. 9 out of 10 adults hospitalized with flu have at least one underlying medical condition. Make your appointment to get your flu shot today! #NIVW
Multi-cancer early detection (MCED) tests are a promising approach to detecting cancer. However, researchers have much to learn about them. NCI is planning clinical trials to understand them better with cancer mortality being the endpoint.
In February 2022, President Biden announced plans “to supercharge the Cancer Moonshot as a central effort of the Biden-Harris administration." #MIHealthSummit #CancerMoonshot
At the @MilkenInstitute summit, @NCIDirector stresses that making continued progress against cancer will require collaboration across disciplines and agencies, as well as contributions from patients and advocates. Everyone has a role to play. #MIHealthSummit
(1/2) Today, @NCIDirector Dr. Monica Bertagnolli will join a panel discussion at the Milken Institute’s Future of Health Summit at approximately 7:15pm ET (12/06). Watch live:
Are you an NCI-funded junior faculty? The NCI Awardee Skills Development Consortium (NASDC) is currently accepting applications. NASDC provides important and educational career development opportunities for NCI grantees. Learn more and apply.
A study in India has found that an ultra-low dose of the #immunotherapy drug nivolumab helped some people with head and neck cancer live longer. Because the dose is 6% of what’s often used in the U.S. and Europe, it is potentially more affordable.
NCI community health educators and partners aim to increase #ColorectalCancer screenings through #ScreentoSave, a program designed for racially and ethnically diverse communities and in rural areas.
NCI's CCDI Molecular Characterization Initiative is enrolling children and AYAs newly diagnosed with #RareTumors and other #ChildhoodCancers. Potential participants must be receiving care from a @COGorg-affiliated hospital.